Skip to Content

Join the 'Onzetra Xsail' group to help and get support from people like you.

Onzetra Xsail News

Migraine Linked to Higher Stroke Risk After Surgery

Posted 11 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 11, 2017 – Migraine sufferers may face a slightly higher risk of stroke after an operation, a new study suggests. The risk appears greatest among those who experience migraine with aura, where the headache also includes a visual disturbance, such as the appearance of flashing lights. People with these types of migraines have more than double the risk of stroke after surgery compared to people without migraines, the study found. And the odds that someone who has migraines without aura will have a stroke after surgery are still 75 percent higher than people not afflicted by migraines, the study found. However, experts stressed that the absolute risk of anyone suffering a stroke after a surgery is still very low, so people with migraine shouldn't be alarmed. Even with the increased risk, only about six out of every 1,000 patients with migraines with aura will experience a ... Read more

Related support groups: Headache, Migraine, Ischemic Stroke, Migraine Prevention, Migraine Prophylaxis, Imitrex, Maxalt, Sumatriptan, Cafergot, Relpax, Zomig, Treximet, Ischemic Stroke - Prophylaxis, Midrin, Ergotamine, Maxalt-MLT, Rizatriptan, Frova, Migranal, Dihydroergotamine

Migraines Take Toll on Spouse

Posted 31 May 2016 by Drugs.com

TUESDAY, May 31, 2016 – If you suffer from migraines, your spouse probably suffers, too. That's the conclusion of researchers who surveyed more than 4,000 people with the debilitating headaches and their spouses/domestic partners. "This study highlights the significant burden that migraine can have on a wide range of family activities, parenting responsibilities, spousal relationships and family finances," said lead author Dawn Buse, director of behavioral medicine at Montefiore Headache Center in New York City. More than two out of five people with migraines and 23 percent of their spouses/partners said they believed the person with migraines would be a better parent if they did not have the condition. About half of the people with migraines had missed at least one family activity in the past month because of a migraine, the study found. About one-third of migraine sufferers and 21 ... Read more

Related support groups: Migraine, Ibuprofen, Naproxen, Meloxicam, Migraine Prevention, Advil, Diclofenac, Voltaren, Aleve, Mobic, Fioricet, Motrin, Excedrin, Indomethacin, Migraine Prophylaxis, Imitrex, Tylenol PM, Maxalt, Sumatriptan, Toradol

Health Tip: Have Headaches? Speak to Your Doctor

Posted 24 May 2016 by Drugs.com

-- A headache is generally recognized as having pain or discomfort anywhere in the head, scalp or neck. It can be a symptom of everything from minor stress to a life-threatening stroke. Learning all you can about your condition is a first step on the road to treatment and prevention. The National Headache Foundation suggests: Learn as much a possible, such as what's probably causing your headaches and how to prevent them. Focus on the most important questions, and get answers to less important questions later. Voice any concerns or fears about your headaches to your doctor. If you don't understand something, ask the doctor for an explanation. Read more

Related support groups: Headache, Migraine, Ibuprofen, Naproxen, Meloxicam, Migraine Prevention, Advil, Diclofenac, Voltaren, Aleve, Mobic, Fioricet, Motrin, Excedrin, Cluster Headaches, Indomethacin, Migraine Prophylaxis, Imitrex, Tylenol PM, Maxalt

Giving the 'Green Light' to Migraine Relief

Posted 17 May 2016 by Drugs.com

TUESDAY, May 17, 2016 – A new study sheds light – literally – on a potential means of easing migraine pain. Researchers in Boston exposed 69 migraine patients to different colors of light. They found that while blue light exacerbated headache pain, a narrow spectrum of low-intensity green light significantly reduced light sensitivity. In some cases, this green light also reduced migraine pain by about 20 percent, the researchers found. They noted that migraine headache affects nearly 15 percent of people worldwide, and a frequent symptom of migraine is light sensitivity, also known as photophobia. "Although photophobia is not usually as incapacitating as headache pain itself, the inability to endure light can be disabling," study author Rami Burstein, of Beth Israel Deaconess Medical Center in Boston, said in a medical center news release. "More than 80 percent of migraine attacks ... Read more

Related support groups: Migraine, Celebrex, Fioricet, Excedrin, Imitrex, Tylenol PM, Maxalt, Sumatriptan, Seasonal Affective Disorder, Fiorinal, Excedrin Migraine, Cafergot, Advil PM, Relpax, Zomig, Treximet, Midrin, Vioxx, Ergotamine, Esgic

Stroke Risk May Be Greater for Certain Migraine Sufferers: Studies

Posted 18 Feb 2016 by Drugs.com

WEDNESDAY, Feb. 17, 2016 – Migraine sufferers may face an increased risk of stroke if they suffer from visual symptoms called auras or if they take the female hormone estrogen, a pair of new studies suggests. People who have migraine headaches with auras may be 2.4 times more likely to have a stroke caused by a blood clot, compared to migraine patients who don't see auras, says one study scheduled for presentation Wednesday at the American Stroke Association's annual meeting, in Los Angeles. And, women with more severe migraines who take hormone-replacement therapy may be 30 percent more likely to suffer a clot-based stroke than women not taking medication containing estrogen, according to a second paper to be presented at the meeting. The two risk factors could combine to pose a dangerous mix for some women, said Dr. Elizabeth Loder, chief of the headache and pain division at Brigham ... Read more

Related support groups: Migraine, Ischemic Stroke, Migraine Prevention, Migraine Prophylaxis, Transient Ischemic Attack, Imitrex, Maxalt, Sumatriptan, Cafergot, Relpax, Zomig, Treximet, Midrin, Ischemic Stroke - Prophylaxis, Ergotamine, Rizatriptan, Maxalt-MLT, Frova, Migranal, Dihydroergotamine

FDA Approves Onzetra Xsail (sumatriptan nasal powder) for the Acute Treatment of Migraine

Posted 3 Feb 2016 by Drugs.com

ALISO VIEJO, Calif., January 28, 2016 – Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Onzetra Xsail (sumatriptan nasal powder), formerly known as AVP-825, for the acute treatment of migraine with or without aura in adults. Onzetra Xsail is an intranasal medication delivery system consisting of a low-dose (22mg) of sumatriptan powder that is delivered utilizing the novel Xsail™ Breath Powered Delivery Device. Onzetra Xsail is a fast-acting dry powder formulation of sumatriptan, the most commonly prescribed migraine medication. “While there are many acute migraine treatment options available, more than 70% of patients are not fully satisfied with their current migraine treatment. Given this high dissatisfaction, there remains an unmet need to provide patients with fast-acting, well tolerated therapies that deliver consistent re ... Read more

Related support groups: Migraine, Sumatriptan, Onzetra Xsail

Ask a Question

Further Information

Related Condition Support Groups

Migraine

Onzetra Xsail Patient Information at Drugs.com